Weekly influenza surveillance overview March 30 2012 - Week 12
The weekly influenza surveillance overview is a collection of timely and relevant information regarding influenza activity in Europe.
Rapid risk assessment, update: Severe respiratory disease associated with a novel coronavirus
CDC updated risk assessment concludes that in the absence of evidence of sustained person-to-person transmission outside of household settings, the current facts still point towards a hypothesis of a zoonotic or environmental source with occasional transmission to exposed humans. WHO does not advise any travel or trade restrictions at this point for KSA or Qatar.
Rapid Risk Assessment: Severe respiratory disease associated with a novel coronavirus
New and noteworthy in this update: the retrospective identification of novel coronavirus in biological samples from two fatal cases in Jordan (April 2012) and the results of a joint ECDC/WHO survey which confirms that EU/EEA Member States have an adequate capacity to detect novel coronavirus through their network of national reference laboratories: 18 of 30 in EU/EEA countries are capable of confirming positive screened samples by either ORF1b RT-PCR or other target RT-PCR assays with sequence analysis or whole-genome sequence analysis.
Respiratory tract infections - Annual epidemiological report for 2012-13
The Annual Epidemiological Report 2014 gives an overview of the epidemiology of communicable diseases of public health significance in Europe, drawn from surveillance information on the 52 communicable diseases and health issues for which surveillance is mandatory in the European Union and European Economic Area countries. The respiratory tract infections chapter from the upcoming ECDC Annual Epidemiological Report 2014 is now available as a separate report and provides a snapshot of the epidemiological situation in Europe across a number of diseases.
Severe acute respiratory syndrome - Annual Epidemiological Report 2016 [2014 data]
Knowledge about the epidemiology and ecology of SARS coronavirus infection remains presently incomplete and the risk of re-emergence is unpredictable. The rapid spread of SARS worldwide showed the need to maintain surveillance despite the disease’s absence since 2003.
Severe acute respiratory syndrome (SARS) - Annual Epidemiological Report for 2015
There were no cases of SARS in the EU/EEA 2015.
Technical guidance on risk assessment guidelines for diseases transmitted on aircraft (RAGIDA). Part 2: Operational guidelines - Second edition
In the closed cabin environment of modern airplanes, passengers are frequently exposed to various infectious diseases.
Risk assessment guidelines for diseases transmitted on aircraft (RAGIDA) - Part 2: Operational guidelines for assisting the evaluation of risk for transmission by disease
In June 2009, ECDC convened a technical expert consultation that focused on tuberculosis, new emerging airborne diseases (e.g. SARS) and meningococcal infections. This consultation was the second of a two-part process intended to assist national authorities in the EU Member States in the assessment of risks associated with the transmission of various infectious agents on board airplanes.
Risk assessment guidelines for infectious diseases transmitted on aircraft
In the closed cabin environment of modern airplanes, passengers are frequently exposed to various infectious diseases. This report looks at 12 infectious diseases and, by systematically evaluating literature on on-board transmission, attempts to assess the risk of infection via air circulation in airplanes.
These guidelines are complemented by operational guidelines in relation to tuberculosis, new emerging airborne diseases (e.g. SARS) and meningococcal infections.